Wu Qian Vicky相关文献与解析，生知库 | 链接生命科学的每一步

Vaquera-Alfaro, Héctor A; Jeon, Yein; Wu, Qian Vicky; Liang, Emily C; Portuguese, Andrew; Gómez-De León, Andrés; Valdespino-Valdes, Jorge; Gauthier, Jordan

细胞生物学

发表日期：2026

文献求助收藏

Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration

用于肿瘤学研究中时变协变量生存分析的新型 R Shiny 工具：克服偏差并增强协作

期刊:JCO Clinical Cancer Informatics

影响因子:2.8

doi:10.1200/CCI-25-00225

Li, Yimei; Qiao, Yang; Gao, Fei; Gauthier, Jordan; Zhang, Qiang Ed; Voutsinas, Jenna; Leisenring, Wendy; Gooley, Ted; Summers, Corinne; Hirayama, Alexandre; Turtle, Cameron J; Gardner, Rebecca; Zee, Jarcy; Wu, Qian Vicky

Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up

真实世界中 lisocabtagene maraleucel 和 axicabtagene ciloleucel 在大 B 细胞淋巴瘤中的比较：一项为期 3 年的逆概率加权分析

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2024.287010

Portuguese, Andrew J; Huang, Jennifer J; Jeon, Yein; Taheri, Mahnoosh; Albittar, Aya; Liang, Emily C; Hirayama, Alexandre V; Kimble, Erik L; Iovino, Lorenzo; Poh, Christina; Gopal, Ajay K; Shadman, Mazyar; Till, Brian G; Milano, Filippo; Chapuis, Aude G; Otegbeye, Folashade; Cassaday, Ryan D; Basom, Ryan S; Wu, Qian Vicky; Maloney, David G; Gauthier, Jordan

Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL

研究性 CAR-T 细胞疗法治疗复发难治性婴儿急性淋巴细胞白血病的可行性及良好疗效

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2024012638

Annesley, Colleen; Lamble, Adam; Summers, Corinne; Pulsipher, Michael A; Wayne, Alan S; Rivers, Julie; Huang, Wenjun; Wilson, Ashley; Wu, Qian Vicky; Seidel, Kristy; Mgebroff, Stephanie; Brown, Christopher; Lindgren, Catherine; Park, Julie R; Jensen, Michael; Gardner, Rebecca

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

一项针对初治成人B细胞急性淋巴细胞白血病患者的CD19 CAR T细胞疗法（携带全人源scFv）的I期研究

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2024015314

Gauthier, Jordan; Liang, Emily C; Huang, Jennifer J; Kimble, Erik L; Hirayama, Alexandre V; Fiorenza, Salvatore; Voutsinas, Jenna M; Wu, Qian Vicky; Jaeger-Ruckstuhl, Carla A; Pender, Barbara S; Kirchmeier, Delaney R; Torkelson, Aiko; Braathen, Kristina; Basom, Ryan; Shadman, Mazyar; Kopmar, Noam E; Cassaday, Ryan D; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J

[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer

[18F]-氟雌二醇PET（FES-PET）和[18F]氟代脱氧葡萄糖PET（FDG-PET）显像可能有助于转移性小叶乳腺癌患者的治疗管理

期刊:Molecular Imaging and Biology

影响因子:2.5

doi:10.1007/s11307-025-02015-2

Manohar, Poorni M; Peterson, Lanell M; Jenkins, Isaac C; Wu, Qian Vicky; Kurland, Brenda F; Novakova-Jiresova, Alena; Muzi, Mark; Chen, Delphine L; Specht, Jennifer M; Dintzis, Suzanne; Kinahan, Paul E; Mankoff, David A; Linden, Hannah M

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors

利用外周血生物标志物构建免疫检查点抑制剂治疗头颈部鳞状细胞癌患者总生存期的预后特征

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-024-13051-6

Pan, Cassie; Ng, Kevin; Voutsinas, Jenna; Barber, Brittany; Rizvi, Zain H; Marchiano, Emily; Ferrandino, Rocco M; Futran, Neal; Laramore, George E; Liao, Jay J; Parvathaneni, Upendra; Panjwani, Neil; Martins, Renato G; Rodriguez, Cristina P; Wu, Qian Vicky

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

在儿童CD19-CAR T细胞患者中，神经毒性期间GFAP和NfL水平从较高的基线水平升高。

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2022008119

Gust, Juliane; Rawlings-Rhea, Stephanie D; Wilson, Ashley L; Tulberg, Niklas M; Sherman, Amber L; Seidel, Kristy D; Wu, Qian Vicky; Park, Julie R; Gardner, Rebecca A; Annesley, Colleen E

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

阿那白滞素用于治疗嵌合抗原受体T细胞疗法后难治性细胞因子释放综合征或免疫效应细胞相关神经毒性综合征

期刊:Transplantation and Cellular Therapy

影响因子:4.4

doi:10.1016/j.jtct.2023.04.001

Gazeau, Nicolas; Liang, Emily C; Wu, Qian Vicky; Voutsinas, Jenna M; Barba, Pere; Iacoboni, Gloria; Kwon, Mi; Ortega, Juan Luis Reguera; López-Corral, Lucía; Hernani, Rafael; Ortiz-Maldonado, Valentín; Martínez-Cibrian, Nuria; Martinez, Antonio Perez; Maziarz, Richard T; Williamson, Staci; Nemecek, Eneida R; Shadman, Mazyar; Cowan, Andrew J; Green, Damian J; Kimble, Erik; Hirayama, Alexandre V; Maloney, David G; Turtle, Cameron J; Gauthier, Jordan

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors

外周血淋巴细胞和乳酸脱氢酶与接受免疫检查点抑制剂治疗的头颈癌患者的疗效和生存率相关。

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.5697

Pan, Cassie; Wu, Qian Vicky; Voutsinas, Jenna; Houlton, Jeffrey J; Barber, Brittany; Rizvi, Zain H; Marchiano, Emily; Futran, Neal; Laramore, George E; Liao, Jay J; Parvathaneni, Upendra; Martins, Renato G; Fromm, Jonathan R; Rodriguez, Cristina P

A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy Research

移植和细胞治疗研究竞争风险分析实用指南

Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration

用于肿瘤学研究中时变协变量生存分析的新型 R Shiny 工具：克服偏差并增强协作

Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up

真实世界中 lisocabtagene maraleucel 和 axicabtagene ciloleucel 在大 B 细胞淋巴瘤中的比较：一项为期 3 年的逆概率加权分析

Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL

研究性 CAR-T 细胞疗法治疗复发难治性婴儿急性淋巴细胞白血病的可行性及良好疗效

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL

一项针对初治成人B细胞急性淋巴细胞白血病患者的CD19 CAR T细胞疗法（携带全人源scFv）的I期研究

[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer

[18F]-氟雌二醇PET（FES-PET）和[18F]氟代脱氧葡萄糖PET（FDG-PET）显像可能有助于转移性小叶乳腺癌患者的治疗管理

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors

利用外周血生物标志物构建免疫检查点抑制剂治疗头颈部鳞状细胞癌患者总生存期的预后特征

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

在儿童CD19-CAR T细胞患者中，神经毒性期间GFAP和NfL水平从较高的基线水平升高。

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

阿那白滞素用于治疗嵌合抗原受体T细胞疗法后难治性细胞因子释放综合征或免疫效应细胞相关神经毒性综合征

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors

外周血淋巴细胞和乳酸脱氢酶与接受免疫检查点抑制剂治疗的头颈癌患者的疗效和生存率相关。